vTv Therapeutics Appoints Thomas Strack, M.D., as Chief Medical Officer
GlobeNewswire
HIGH POINT, N.C., Nov. 02, 2023 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical stage biopharmaceutical..
HIGH POINT, N.C., Nov. 02, 2023 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical stage biopharmaceutical..
By Julian Lindley-French and Franco Algieri (With the support of The Alphen Group)
The primary purpose of this article..